Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma

SIMPLE SUMMARY: Patients with extensive-stage small cell lung cancer (ED-SCLC) have a very short survival time even if they receive standard chemotherapy. Currently, the combination of chemotherapy plus immune checkpoint inhibitors (ICIs) as the first line treatment had superior survival than chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsiao-Ling, Tu, Yu-Kang, Chang, Hsiu-Mei, Lee, Tai-Huang, Wu, Kuan-Li, Tsai, Yu-Chen, Lee, Mei-Hsuan, Yang, Chih-Jen, Hung, Jen-Yu, Chong, Inn-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761843/
https://www.ncbi.nlm.nih.gov/pubmed/33287455
http://dx.doi.org/10.3390/cancers12123629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761843/
https://www.ncbi.nlm.nih.gov/pubmed/33287455
http://dx.doi.org/10.3390/cancers12123629

Ejemplares similares